Cyclosporine in Treating Patients With Low Blood Counts Caused By Hematologic Cancer

Completed · Phase 2

Conditions studied: Anemia, Leukemia, Neutropenia, Thrombocytopenia

In brief

RATIONALE: Cyclosporine may improve low blood counts caused by hematologic cancer. PURPOSE: Phase II trial to study the effectiveness of cyclosporine in treating patients who have low blood counts caused by hematologic cancer.

Key facts

Study ID

NCT00031980

Run by

Alliance for Clinical Trials in Oncology

People needed

30

Starts

2002-03-01

Expected to finish

2005-05-01

Last updated by the study team

2016-07-06

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Roswell Park Cancer Institute — Buffalo, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.